(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification Number) |
N/A | ||
(Address of principal executive offices) | (Zip Code) |
Title of Each Class | Trading Symbol(s) | Name of Each Exchange on Which Registered | ||
☒ | Accelerated filer | ☐ | |
Non-accelerated filer | ☐ | Smaller reporting company | |
Emerging growth company | |||
Page | ||
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS | ||
PART I | FINANCIAL INFORMATION | |
Item 1. | Financial Statements | |
Condensed Consolidated Statements of Operations for the three months ended March 31, 2026 and March 31, 2025 | ||
Condensed Consolidated Statements of Comprehensive Income for the three months ended March 31, 2026 and March 31, 2025 | ||
Condensed Consolidated Balance Sheets as of March 31, 2026 and December 31, 2025 | ||
Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2026 and March 31, 2025 | ||
Condensed Consolidated Statements of Changes in Equity for the three months ended March 31, 2026 and March 31, 2025 | ||
Notes to Condensed Consolidated Financial Statements | ||
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | |
Item 3. | Quantitative and Qualitative Disclosures About Market Risk | |
Item 4. | Controls and Procedures | |
PART II | OTHER INFORMATION | |
Item 1. | Legal Proceedings | |
Item 1A. | Risk Factors | |
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | |
Item 3. | Defaults Upon Senior Securities | |
Item 4. | Mine Safety Disclosures | |
Item 5. | Other Information | |
Item 6. | Exhibits | |
Signatures |
Three months ended March 31, | |||
2026 | 2025 | ||
Net sales | $ | $ | |
Cost of goods sold | ( | ( | |
Gross profit | |||
Selling, general and administrative expenses | ( | ( | |
Impairment and restructuring costs | ( | ( | |
Transaction and integration-related expenses associated with the Combination | ( | ||
Operating profit | |||
Interest expense, net | ( | ( | |
Pension and other postretirement non-service income, net | |||
Other expense, net | ( | ( | |
Income before income taxes | |||
Income tax expense | ( | ( | |
Net income | |||
Net loss attributable to noncontrolling interests | |||
Net income attributable to common shareholders | $ | $ | |
Basic earnings per share attributable to common shareholders | $ | $ | |
Diluted earnings per share attributable to common shareholders | $ | $ | |
The accompanying notes are an integral part of these Unaudited Condensed Consolidated Financial Statements. | |||
Three months ended March 31, | |||
2026 | 2025 | ||
Net income | $ | $ | |
Other comprehensive (loss) income, net of tax: | |||
Foreign currency translation (loss) gain | ( | ||
Defined benefit pension and other postretirement benefit plans | ( | ||
Net gain on cash flow hedges | |||
Other comprehensive (loss) income, net of tax | ( | ||
Comprehensive income | |||
Comprehensive loss attributable to noncontrolling interests | |||
Comprehensive income attributable to common shareholders | $ | $ | |
The accompanying notes are an integral part of these Unaudited Condensed Consolidated Financial Statements. | |||
March 31, 2026 | December 31, 2025 | ||
Assets | |||
Current assets: | |||
Cash and cash equivalents (amounts related to consolidated variable interest entities of $ $ | $ | $ | |
Accounts receivable, net (amounts related to consolidated variable interest entities of $ $ | |||
Inventories | |||
Other current assets | |||
Total current assets | |||
Property, plant and equipment, net | |||
Goodwill | |||
Intangibles, net | |||
Prepaid pension asset | |||
Other non-current assets (amounts related to consolidated variable interest entities of $ $ | |||
Total assets | $ | $ | |
Liabilities and Equity | |||
Current liabilities: | |||
Accounts payable | $ | $ | |
Accrued expenses | |||
Accrued compensation and benefits | |||
Current portion of debt | |||
Other current liabilities | |||
Total current liabilities | |||
Non-current debt due after one year (amounts related to consolidated variable interest entities of $ | |||
Deferred tax liabilities | |||
Pension liabilities and other postretirement benefits, net of current portion | |||
Other non-current liabilities (amounts related to consolidated variable interest entities of $ and $ | |||
Total liabilities | |||
Commitments and Contingencies (Note 13) | |||
Equity: | |||
Preferred stock, $ | |||
Common stock, $ shares outstanding at March 31, 2026 and December 31, 2025, respectively | |||
Treasury stock, at cost; 2025, respectively | ( | ( | |
Capital in excess of par value | |||
Accumulated other comprehensive loss | ( | ( | |
Retained earnings | |||
Total shareholders’ equity | |||
Noncontrolling interests | |||
Total equity | |||
Total liabilities and equity | $ | $ |
Three months ended March 31, | |||
2026 | 2025 | ||
Operating activities: | |||
Net income | $ | $ | |
Adjustments to reconcile consolidated net income to net cash provided by operating activities: | |||
Depreciation, depletion and amortization | |||
Impairment of assets | |||
Cash surrender value increase in excess of premiums paid | ( | ( | |
Share-based compensation expense | |||
Deferred income tax benefit | ( | ( | |
Pension and other postretirement funding more than cost | ( | ( | |
Other | ( | ||
Change in operating assets and liabilities, net of acquisitions and divestitures: | |||
Accounts receivable | ( | ( | |
Inventories | ( | ||
Other assets | ( | ( | |
Accounts payable | ( | ( | |
Income taxes | ( | ( | |
Accrued liabilities and other | ( | ( | |
Net cash provided by operating activities | |||
Investing activities: | |||
Capital expenditures | ( | ( | |
Cash paid for purchase of businesses, net of cash acquired | ( | ( | |
Proceeds from corporate owned life insurance | |||
Proceeds from sale of property, plant and equipment | |||
Other | |||
Net cash used for investing activities | ( | ( | |
Financing activities: | |||
Additions to debt | |||
Repayments of debt | ( | ( | |
Debt issuance costs | ( | ( | |
Changes in commercial paper, net | |||
Other debt additions (repayments), net | ( | ||
Repayments of finance lease liabilities | ( | ( | |
Proceeds from re-issuance of shares from treasury stock | |||
Tax paid in connection with shares withheld from employees | ( | ( | |
Cash dividends paid to shareholders | ( | ( | |
Other | |||
Net cash provided by financing activities | |||
Effect of exchange rate changes on cash and cash equivalents | ( | ||
Decrease in cash and cash equivalents | ( | ( | |
Cash and cash equivalents at beginning of period | |||
Cash and cash equivalents at end of period | $ | $ | |
Shares of Common Stock | Common Stock | Capital in Excess of Par Value | Treasury Stock | Retained Earnings | Accumulated Other Comprehensive Loss | Total Shareholders' Equity | Noncontrolling Interest | Total | |
Balance at December 31, 2025 | $ | $ | $( | $ | $( | $ | $ | $ | |
Net income | — | — | — | — | — | ( | |||
Other comprehensive loss, net of tax | — | — | — | — | — | ( | ( | — | ( |
Share-based compensation | — | — | — | — | — | — | |||
Shares distributed by Smurfit Kappa Employee Trust, net of tax paid in connection with shares withheld from employees | — | — | ( | ( | — | ( | — | ( | |
Re-issuance of shares by Smurfit Kappa Employee Trust | — | — | — | — | — | ||||
Issuance of common stock net of tax paid in connection with shares withheld from employees | — | — | ( | — | ( | — | ( | ||
Cancellation of shares held in treasury stock by Smurfit Kappa Employee Trust | — | — | — | ( | — | — | |||
Dividends declared ($ | — | — | — | ( | — | ( | — | ( | |
Balance at March 31, 2026 | $ | $ | $( | $ | $( | $ | $ | $ |
Shares of Common Stock | Common Stock | Capital in Excess of Par Value | Treasury Stock | Retained Earnings | Accumulated Other Comprehensive Loss | Total Shareholders' Equity | Noncontrolling Interest | Total | |
Balance at December 31, 2024 | $ | $ | $( | $ | $( | $ | $ | $ | |
Net income | — | — | — | — | — | ( | |||
Other comprehensive income, net of tax | — | — | — | — | — | — | |||
Share-based compensation | — | — | — | — | — | — | |||
Shares distributed by Smurfit Kappa Employee Trust | — | — | ( | — | — | — | |||
Issuance of common stock net of tax paid in connection with shares withheld from employees | — | — | ( | — | ( | — | ( | ||
Cancellation of shares held in treasury stock by Smurfit Kappa Employee Trust | — | — | — | ( | — | — | |||
Dividends declared ($ | — | — | — | ( | — | ( | — | ( | |
Balance at March 31, 2025 | $ | $ | $( | $ | $( | $ | $ | $ |
Three months ended March 31, 2026 | North America | Europe, MEA and APAC | LATAM | Total | |||
Net sales (unaffiliated customers) | $ | $ | $ | $ | |||
Add net sales (intersegment) | |||||||
Net sales (aggregate) | |||||||
Less segment expenses: | |||||||
Segment cost of goods sold | ( | ( | ( | ||||
Segment selling, general and administrative expenses | ( | ( | ( | ||||
( | ( | ( | ( | ||||
Segment Adjusted EBITDA | $ | $ | $ | $ | |||
Unallocated corporate costs | ( | ||||||
Depreciation, depletion and amortization | ( | ||||||
Impairment and restructuring costs | ( | ||||||
Interest expense, net | ( | ||||||
Pension and other postretirement non-service income, net | |||||||
Share-based compensation expense | ( | ||||||
Other expense, net | ( | ||||||
Other adjustments | ( | ||||||
Income before income taxes | $ |
Three months ended March 31, 2025 | North America | Europe, MEA and APAC | LATAM | Total | |||
Net sales (unaffiliated customers) | $ | $ | $ | $ | |||
Add net sales (intersegment) | |||||||
Net sales (aggregate) | |||||||
Less segment expenses: | |||||||
Segment cost of goods sold | ( | ( | ( | ||||
Segment selling, general and administrative expenses | ( | ( | ( | ||||
( | ( | ( | ( | ||||
Segment Adjusted EBITDA | $ | $ | $ | $ | |||
Unallocated corporate costs | ( | ||||||
Depreciation, depletion and amortization | ( | ||||||
Impairment and restructuring costs | ( | ||||||
Transaction and integration-related expenses associated with the Combination | ( | ||||||
Interest expense, net | ( | ||||||
Pension and other postretirement non-service income, net | |||||||
Share-based compensation expense | ( | ||||||
Other expense, net | ( | ||||||
Other adjustments | ( | ||||||
Income before income taxes | $ |
Three months ended March 31, | |||
2026 | 2025 | ||
Capital expenditures: | |||
North America | $ | $ | |
Europe, MEA and APAC | |||
LATAM | |||
Total per reportable segments | |||
Corporate | |||
Total capital expenditures | $ | $ | |
Three months ended March 31, 2026 | |||||||
North America | Europe, MEA and APAC | LATAM | Total | ||||
Revenue by product: | |||||||
Paper | $ | $ | $ | $ | |||
Packaging | |||||||
Total | $ | $ | $ | $ | |||
Three months ended March 31, 2025 | |||||||
North America | Europe, MEA and APAC | LATAM | Total | ||||
Revenue by product: | |||||||
Paper | $ | $ | $ | $ | |||
Packaging | |||||||
Total | $ | $ | $ | $ | |||
March 31, | December 31, | ||
2026 | 2025 | ||
Gross accounts receivable | $ | $ | |
Less: Allowances | ( | ( | |
Accounts receivable | $ | $ |
March 31, | December 31, | ||
2026 | 2025 | ||
Finished goods | $ | $ | |
Work-in-progress | |||
Raw materials | |||
Consumables and spare parts | |||
Inventories | $ | $ |
March 31, | December 31, | ||
2026 | 2025 | ||
Land and buildings | $ | $ | |
Plant and equipment | |||
Construction-in-progress | |||
Finance lease right-of-use assets | |||
Property, plant and equipment at cost, excluding forestlands | |||
Less: Accumulated depreciation and impairment | ( | ( | |
Property, plant and equipment, net, excluding forestlands | |||
Forestlands, net of depletion | |||
Property, plant and equipment, net | $ | $ |
Three months ended March 31, | |||
2026 | 2025 | ||
Interest expense | $( | $( | |
Interest income | |||
Interest expense, net | $( | $( | |
March 31, 2026 | December 31, 2025 | ||||||
Book Value | Fair Value | Book Value | Fair Value | ||||
Debt with fixed interest rates | $ | $ | $ | $ | |||
Three months ended March 31, | |||
2026 | 2025 | ||
Receivable from financial institutions at January 1 | $ | $ | |
Receivables sold to the financial institutions and derecognized | ( | ( | |
Receivables collected by financial institutions | |||
Cash payments to financial institutions | ( | ( | |
Receivable from financial institutions at March 31 | $ | $ | |
March 31, | December 31, | ||
2026 | 2025 | ||
$ | $ | $ | |
$ | |||
$ | |||
$ | |||
€ | |||
€ | |||
€ | |||
$ | |||
$ | |||
$ | |||
€ | |||
$ | |||
$ | |||
€ | |||
$ | |||
€ | |||
$ | |||
$ | |||
$ | |||
€ | |||
$ | |||
$ | |||
$ | |||
Commercial paper | |||
Vendor financing and commercial card programs | |||
Farm credit facility | |||
Other bank loans | |||
Finance lease obligations | |||
Total debt, excluding fair value adjustments, bond discounts and debt issuance costs | |||
Unamortized fair value adjustments, bond discounts and debt issuance costs | ( | ( | |
Total debt | |||
Less: Current portion of debt | ( | ( | |
Non-current debt due after one year | $ | $ |
Defined Benefit Pension Plans | |||||||
U.S. Plans | Non-U.S. Plans | ||||||
Three months ended March 31, | |||||||
2026 | 2025 | 2026 | 2025 | ||||
Service cost | $ | $ | $ | $ | |||
Interest cost | |||||||
Expected return on assets | ( | ( | ( | ( | |||
Amortization of: | |||||||
Net actuarial loss | |||||||
Prior service credit | ( | ||||||
Net periodic benefit (income) cost | $( | $( | $ | $ | |||
Three months ended March 31, | |||
2026 | 2025 | ||
Numerator: | |||
Net income attributable to common shareholders | $ | $ | |
Denominator: | |||
Basic weighted average shares outstanding | |||
Effect of dilutive share options | |||
Diluted weighted average shares outstanding | |||
Basic earnings per share attributable to common shareholders | $ | $ | |
Diluted earnings per share attributable to common shareholders | $ | $ | |
March 31, | December 31, | ||
2026 | 2025 | ||
Assets | |||
Current assets: | |||
Cash and cash equivalents | $ | $ | |
Accounts receivable | |||
Inventories | |||
Other current assets | |||
Non-current assets: | |||
Property, plant and equipment, net | |||
Other non-current assets | |||
Total assets | $ | $ | |
Liabilities | |||
Current liabilities: | |||
Accounts payable | $ | $ | |
Current portion of debt | |||
Other current liabilities | |||
Non-current liabilities: | |||
Non-current debt due after one year | |||
Other non-current liabilities | |||
Total liabilities | $ | $ |
Foreign Currency Translation | Cash Flow Hedges | Defined Benefit Pension and Other Postretirement Benefit Plans | Other Adjustments(1) | Total (2) | |
Balance at December 31, 2024 | $ | $ | $ | $( | $ |
Other comprehensive (income) loss | ( | ( | ( | ||
Balance at March 31, 2025 | $ | $ | $ | $( | $ |
Balance at December 31, 2025 | $ | $ | $ | $( | $ |
Other comprehensive loss (income) | ( | ( | |||
Balance at March 31, 2026 | $ | $ | $ | $( | $ |
Three months ended March 31, | |||||||
2026 | 2025 | ||||||
Pre-Tax | Tax | Net of Tax | Pre-Tax | Tax | Net of Tax | ||
Foreign currency translation (loss) gain | $( | $ | $( | $ | $ | $ | |
Defined benefit pension and other postretirement benefit plans: | |||||||
Amortization and settlement recognition of net actuarial loss | ( | ||||||
Amortization of prior service credit | ( | ( | |||||
Foreign currency gain (loss) - pensions | ( | ( | |||||
Changes in fair value of cash flow hedges | |||||||
Consolidated other comprehensive (loss) income | ( | ( | ( | ||||
Other comprehensive loss (income) attributable to noncontrolling interests | |||||||
Other comprehensive (loss) income attributable to common shareholders | $( | $( | $( | $ | $ | $ | |
Three months ended March 31, | ||||
2026 | 2025 | |||
Net sales | $7,712 | $7,656 | ||
Cost of goods sold | (6,444) | (6,079) | ||
Gross profit | 1,268 | 1,577 | ||
Selling, general and administrative expenses | (961) | (973) | ||
Impairment and restructuring costs | (54) | (15) | ||
Transaction and integration-related expenses associated with the Combination | — | (36) | ||
Operating profit | 253 | 553 | ||
Interest expense, net | (166) | (167) | ||
Pension and other postretirement non-service income, net | 8 | 9 | ||
Other expense, net | (11) | (5) | ||
Income before income taxes | 84 | 390 | ||
Income tax expense | (21) | (8) | ||
Net income | 63 | 382 | ||
Net loss attributable to noncontrolling interests | 2 | 2 | ||
Net income attributable to common shareholders | $65 | $384 | ||
Three months ended March 31, | ||||
2026 | 2025 | |||
Net sales (aggregate):(1) | ||||
North America | $4,502 | $4,669 | ||
Europe, MEA and APAC | 2,771 | 2,582 | ||
LATAM | 540 | 513 | ||
Segment Adjusted EBITDA: | ||||
North America | $597 | $785 | ||
Europe, MEA and APAC | 421 | 389 | ||
LATAM | 109 | 115 | ||
Three months ended March 31, | |||
2026 | 2025 | ||
Net cash provided by operating activities | $204 | $235 | |
Net cash used for investing activities | $(627) | $(476) | |
Net cash provided by financing activities | $209 | $151 | |
Three months ended March 31, | ||||
2026 | 2025 | |||
Net income | $63 | $382 | ||
Income tax expense | 21 | 8 | ||
Depreciation, depletion and amortization | 728 | 603 | ||
Impairment and restructuring costs | 54 | 15 | ||
Transaction and integration-related expenses associated with the Combination | — | 36 | ||
Interest expense, net | 166 | 167 | ||
Pension and other postretirement non-service income, net | (8) | (9) | ||
Share-based compensation expense | 28 | 43 | ||
Other expense, net | 11 | 5 | ||
Other adjustments | 13 | 2 | ||
Adjusted EBITDA | $1,076 | $1,252 | ||
SUMMARIZED STATEMENT OF OPERATIONS | Three months ended March 31, |
2026 | |
Net sales to unrelated parties | $355 |
Net sales to Non-Obligor Subsidiaries | 305 |
Gross profit | 151 |
Interest expense, net with unrelated parties | (152) |
Interest expense, net with Non-Obligor Subsidiaries | (79) |
Net income and net income attributable to the Obligor Group | 527 |
SUMMARIZED BALANCE SHEETS | March 31, | December 31, | |
2026 | 2025 | ||
ASSETS | |||
Current amounts due from Non-Obligor Subsidiaries | $4,631 | $4,571 | |
Other current assets | 955 | 1,207 | |
Total current assets | $5,586 | $5,778 | |
Non-current amounts due from Non-Obligor Subsidiaries | $3,330 | $3,355 | |
Other non-current assets | 932 | 918 | |
Total non-current assets | $4,262 | $4,273 | |
LIABILITIES | |||
Current amounts due to Non-Obligor Subsidiaries | $8,305 | $9,130 | |
Other current liabilities | 1,039 | 482 | |
Total current liabilities | $9,344 | $9,612 | |
Non-current amounts due to Non-Obligor Subsidiaries | $7,380 | $7,447 | |
Other non-current liabilities | 11,682 | 11,823 | |
Total non-current liabilities | $19,062 | $19,270 |
Period | Total Number of Shares Purchased(1) | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Programs | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs | |||
January 1, 2026 – January 31, 2026 | — | $— | — | — | |||
February 1, 2026 – February 28, 2026 | 21,252 | 51.42 | — | — | |||
March 1, 2026 – March 31, 2026 | — | — | — | — | |||
Total | 21,252 | — |
Exhibit Number | Description of Exhibit | ||
3.1 | |||
22 | |||
31.1† | |||
31.2† | |||
32†* | |||
101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.** | ||
101.SCH | Inline XBRL Taxonomy Extension Schema.** | ||
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase.** | ||
101.DEF | Inline XBRL Taxonomy Extension Definition Document.** | ||
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase.** | ||
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase.** | ||
104 | Cover Page Interactive Data File––the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
Smurfit Westrock plc | ||
Dated: May 1, 2026 | /s/ Anthony Smurfit | |
Name: | Anthony Smurfit | |
Title: | President & Group Chief Executive Officer | |
(Principal Executive Officer) | ||
Smurfit Westrock plc | ||
Dated: May 1, 2026 | /s/ Ken Bowles | |
Name: | Ken Bowles | |
Title: | Executive Vice President & Group Chief Financial Officer | |
(Principal Financial Officer) | ||